Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,071 | -21,727 | -18,242 | -8,598 | -22,230 |
| Depreciation Amortization | 1,378 | 1,004 | 674 | 340 | 1,290 |
| Income taxes - deferred | -10,331 | N/A | N/A | N/A | N/A |
| Accounts receivable | 4,000 | -6,000 | 4,000 | 4,000 | N/A |
| Accounts payable and accrued liabilities | 4,907 | 1,251 | -38 | -40 | N/A |
| Other Working Capital | 177,585 | -3,296 | 7,237 | 2,097 | -13,220 |
| Other Operating Activity | -6,874 | 6,013 | -3,325 | -3,755 | 820 |
| Operating Cash Flow | $144,594 | $-22,755 | $-9,694 | $-5,956 | $-33,340 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -57,287 | -67,534 | 9,710 | -292 | N/A |
| PPE Investments | -557 | -153 | -123 | -78 | -710 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 38,720 |
| Investing Cash Flow | $-57,844 | $-67,687 | $9,587 | $-370 | $38,010 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105,918 | 85,271 | 17 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -190 |
| Financing Cash Flow | $105,918 | $85,271 | $17 | $0 | $-190 |
| Beginning Cash Position | 16,263 | 16,263 | 16,263 | 16,263 | 11,780 |
| End Cash Position | 208,931 | 11,092 | 16,173 | 9,937 | 16,260 |
| Net Cash Flow | $192,668 | $-5,171 | $-90 | $-6,326 | $4,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | 144,594 | -22,755 | -9,694 | -5,956 | -33,340 |
| Capital Expenditure | -557 | -153 | -123 | -78 | N/A |
| Free Cash Flow | 144,037 | -22,908 | -9,817 | -6,034 | -33,340 |